Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01376570 · ClinicalTrials.gov registry record · NA
Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment
A NA study of HIV and Opiate Dependence, sponsored by Albert Einstein College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 242
- Enrollment target
- 3
- Study locations
NCT01376570: Completed NA study of HIV and Opiate Dependence, sponsored by Albert Einstein College of Medicine.
NCT01376570 is a NA study of HIV and Opiate Dependence that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 242 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (45% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01376570, a NA study of HIV and Opiate Dependence, has completed, sponsored by Albert Einstein College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 242 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study will test whether contingency management (monetary vouchers contingent on abstinence from drugs) that reinforces one behavior (achieving abstinence from drugs) leads to improved outcomes in other related behaviors (achieving HIV viral load suppression). In a randomized controlled trial, the investigators propose to test whether an abstinence-reinforcing contingency management intervention improves viral load suppression in HIV-infected drug users.
Primary Outcome
Every 4 weeks participants will undergo phlebotomy to measure HIV viral load. Viral load will be analyzed as a continuous measure (log10 copies/ml). In secondary analyses, viral load will be analyzed dichotomously, as undetectable (\<45 copies/ml) or not.
Conditions Studied
Interventions
- BEHAVIORAL Abstinence-reinforcing contingency management intervention
- BEHAVIORAL Performance Feedback intervention
Study Locations (3)
New York
- Montefiore's Community Clinics (Montefiore Medical Group) - The Bronx
- Albert Einstein College of Medicine Division of Substance Abuse clinics - The Bronx
- Montefiore Infectious Disease Clinic - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 242 participants |
| Start Date | 2012-06 |
| Est. Completion | 2017-08-10 |
| Phase | NA |
What the finished NCT01376570 record still lists
NCT01376570 is an interventional study that assigns participants to a tested intervention. The registered 242 participants enrollment target is mid-sized for trials with a published cap, below the 439-participant average among 303 other HIV trials with a reported enrollment target (45% lower).
The record links to 2 conditions, with HIV appearing as the primary indexed condition, and to 2 interventions - of which Abstinence-reinforcing contingency management intervention is the first listed.
NCT01376570 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01376570 about?
NCT01376570 is a clinical study titled "Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment". This study will test whether contingency management (monetary vouchers contingent on abstinence from drugs) that reinforces one behavior (achieving abstinence from drugs) leads to improved outcomes in other related behaviors (achieving HIV viral load suppression). In a randomized controlled trial, t...
What is the current status of trial NCT01376570?
This trial is currently completed. It is a NA study. The enrollment target is 242 participants. The study started on 2012-06. Estimated completion is 2017-08-10.
What conditions does trial NCT01376570 study?
This clinical trial studies the following conditions: HIV, Opiate Dependence.
What interventions are being tested in trial NCT01376570?
The interventions under investigation include: Abstinence-reinforcing contingency management intervention (BEHAVIORAL), Performance Feedback intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01376570?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01376570 being conducted?
This trial has 3 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01376570's enrollment target sits among peer trials
242 90th of 303 higher than 214 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03556228 · 242 participants · Phase 1
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- NCT04260022 · 242 participants · Phase 1
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
- NCT04459000 · 242 participants · NA
Substance Use Treatment and Access to Resources (STARS) Project
- NCT05644496 · 242 participants · Phase 4
ZYNRELEF for Pain Management in Total Knee Arthroplasty
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia